Xinbang Pharmaceutical responds to the acceptance of bribery case involving its controlling subsidiary and shareholders: currently verifying

On March 3rd, Jinshi Data reported that according to the WeChat official account of the Kaiyang County People's Court, on February 26th, the Kaiyang County People's Court accepted the case of bribery by Guizhou Kekai Pharmaceutical Co., Ltd. and bribery by An Huailue. The 2023 financial report of Xinbang Pharmaceutical shows that Guizhou Kekai Pharmaceutical Co., Ltd. is a holding subsidiary of Xinbang Pharmaceutical, and An Ji is the actual controller of Xinbang Pharmaceutical, with An Huailue being in a concerted action relationship with the actual controller. Public information indicates that An Huailue and An Ji are father and daughter. The Q3 2024 report shows that An Huailue holds 5.04% of Xinbang Pharmaceutical shares. On March 3rd, a reporter contacted the securities affairs representative hotline of Xinbang Pharmaceutical, and the staff stated that they had seen the news in the morning and were verifying it, "We will check according to relevant regulations to see if it meets the announcement requirements."